Nenad Prodanović

A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study

Dae‐Hyun Yoo, Paweł Hrycaj, Pedro C. Miranda et al. · Annals of the Rheumatic Diseases · 2013 · 653 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study

Dae‐Hyun Yoo, Nenad Prodanović, Janusz Jaworski et al. · Annals of the Rheumatic Diseases · 2016 · 280 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy

Jung‐Yoon Choe, Nenad Prodanović, Jaroslaw Niebrzydowski et al. · Annals of the Rheumatic Diseases · 2015 · 166 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Safety, immunogenicity and efficacy after switching from reference infliximab to biosimilar SB2 compared with continuing reference infliximab and SB2 in patients with rheumatoid arthritis: results of a randomised, double-blind, phase III transition study

Josef S Smolen, Jung‐Yoon Choe, Nenad Prodanović et al. · Annals of the Rheumatic Diseases · 2017 · 122 citations · Full text

Life Sciences, Clinical Sciences, Immunology +7

Relationship of reduced cerebral blood flow and heart failure severity in elderly males

Goran Loncar, Biljana Božić Nedeljković, Toplica Lepić et al. · The Aging Male · 2010 · 57 citations · Full text

Medicine, Cardiology, Geriatric Medicine +17